Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients.
about
Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic controlManagement of Diabetic Nephropathy in the Elderly: Special Considerations.Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.Pharmacotherapy of end-stage renal disease.New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication managementType 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients.A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study.Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.CKD as an underrecognized threat to patient safety.Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?Frequency of hypoglycemia and its significance in chronic kidney disease.Insulin degludec: pharmacokinetics in patients with renal impairment.Low agreement between the modified diet and renal disease formula and the Cockcroft-Gault formula for assessing chronic kidney disease in cognitively impaired elderly outpatients.Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.Achieving glycemic control in patients with type 2 diabetes and renal impairment.Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.Hypoglycemia in non-critically ill, hospitalized patients with diabetes: evaluation, prevention, and management.Nutrition Support Team-Led Glycemic Control Program for Critically Ill Patients.Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease.Hyperglycemia and Diabetes Mellitus Following Organ Transplantation.Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus.Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: the impact of renal disease.Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland
P2860
Q26766259-0D58DFE2-9CBB-4FCF-A559-27BCC32D3862Q30353386-CBD1CC18-9162-49A1-87D7-CEB56F4A75BBQ31025919-B2DC770C-4836-4AC8-92D9-7BD048E26778Q33531889-16720182-F6BB-4BC1-9D84-964E3C5D4E5BQ33577423-58F84AF0-14B5-4D70-9F82-564D9ADB330DQ35597739-74F13179-2C37-42A3-B3A5-A9FB9BC14141Q36249553-53EDB0FD-9E66-4998-B595-8FFC84A8F5B6Q36326815-4FE4F396-AB37-44CF-92C5-DDF7888F524BQ36782588-87DD7289-AA66-4BA1-979F-95FE7DE9ABF6Q36935362-E53B193F-E53D-4330-846F-933A2D69FDDEQ37009412-F44753E2-DA83-496E-AB49-977F9AD361EBQ37127547-9C7CCF78-EF78-4D91-995A-9821BA7FFCCAQ37211078-30CA92D3-CE59-498F-9AD4-6BB1B8129380Q37506526-A265A68A-E55F-4C6D-83DA-F29D6148C2EBQ37810410-55CA7AA5-56F1-4D97-BA3F-8635A9DE7678Q38054558-B062BB05-226F-45B6-8896-D500C454FF1FQ38065109-91B87459-EC78-4AD7-9A1E-B37D9D2DDACAQ38086611-5CD70E9E-91AC-4479-8850-99C6ECD8D47DQ38087196-62339889-781B-4A90-ADB8-0CF6A40C6D4EQ38206012-53498DD7-CA56-42ED-A994-6CD42B22437AQ38543658-6619BDB4-50AF-4339-B8EE-AF097D334DA8Q38688345-E212984F-7172-4B49-A619-CAD86F46C9AEQ38709346-74116179-8285-4733-A3EE-B762583CB4A3Q41376557-1C9318DE-6D55-4B33-8D00-4044E43E2515Q42157131-F1CC63A9-8DD2-442B-BE30-ECA4533063F7Q46548079-DF07F3F5-AE12-406A-AF2D-70DCAA6A7349Q46720646-E5DE77C1-403D-47A2-B1FC-30929C81BFD2Q51181930-2CD108C6-6A85-4BA2-B5B1-AA96A3056739Q51394933-A73F0D41-2352-46D3-8A32-C3FBFA9C47B3Q57303538-535EF665-52D2-4357-ACCA-CAA58831C20B
P2860
Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@en
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@nl
type
label
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@en
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@nl
prefLabel
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@en
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@nl
P2093
P1433
P1476
Decreased insulin requirement ...... ated Type 2 diabetic patients.
@en
P2093
Biesenbach G
Eichbauer-Sturm G
Schmekal B
P304
P356
10.1046/J.1464-5491.2003.01025.X
P577
2003-08-01T00:00:00Z